Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003069)

Reversed phase POSITIVE ION MODE (Analysis AN005027)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12
ProBetaine	ME799708	0.70	0.98	0.46	0.59	0.46	4.15	0.70	1.04	0.48	0.60	0.48	4.05
Hypoxanthine	ME799722	0.40	0.47	0.27	0.41	0.27	0.37	1.62	2.27	1.34	2.04	1.34	1.95
Xanthine	ME799723	0.52	0.75	0.45	0.78	0.45	0.68	1.31	2.04	1.10	1.81	1.10	2.11
Serotonin	ME799717	1.62	2.74	0.28	1.68	0.28	0.39	0.94	0.96	1.06	0.96	1.06	0.80
Asp	ME799678	1.72	1.83	0.42	0.89	0.42	0.44	1.07	1.23	1.02	1.09	1.02	1.18
Taurine	ME799712	1.84	2.53	0.70	0.49	0.70	0.58	0.88	0.99	0.89	0.91	0.89	0.88
TrpBetaine	ME799713	1.46	0.26	1.11	0.27	1.11	0.68	1.50	0.31	1.27	0.28	1.27	0.76
3-Met-His	ME799696	0.47	0.44	1.58	0.52	1.58	0.50	0.45	0.43	1.77	0.45	1.77	0.43
beta-Ala	ME799714	0.79	0.86	1.20	0.70	1.20	0.63	0.66	0.72	1.47	0.73	1.47	0.76
Sarcosine	ME799709	1.33	1.31	1.53	1.39	1.53	1.39	0.55	0.68	0.57	0.54	0.57	0.52
3-IAA	ME799720	1.38	0.73	0.86	0.97	0.86	0.75	1.40	0.85	1.00	0.98	1.00	0.72
Trp	ME799692	1.00	0.77	0.96	0.92	0.96	0.85	1.13	0.90	1.12	1.08	1.12	0.90
Met-SO	ME799706	1.11	0.74	0.95	0.78	0.95	0.82	1.20	0.95	1.11	0.84	1.11	0.99
Phe	ME799688	1.03	0.86	0.94	0.93	0.94	0.95	1.12	0.95	1.08	0.93	1.08	1.00
Tyr	ME799693	1.12	0.84	0.93	0.90	0.93	0.95	1.16	0.94	1.06	0.91	1.06	0.96
Cys	ME799679	0.88	0.87	0.89	0.96	0.89	1.00	1.04	0.97	1.13	1.14	1.13	1.14
Kynurenine	ME799705	0.90	0.84	0.96	1.01	0.96	1.01	0.97	0.94	1.12	1.05	1.12	1.06
AABA	ME799697	1.02	0.89	0.93	1.16	0.93	0.97	1.03	0.88	1.07	1.09	1.07	0.88
Cortisol	ME799719	1.03	0.77	0.92	1.09	0.92	1.01	1.14	0.81	1.05	1.10	1.05	0.99
Leu	ME799685	1.07	0.84	0.88	1.15	0.88	1.05	1.13	0.92	1.01	1.12	1.01	1.00
Ile	ME799684	1.05	0.84	0.91	1.08	0.91	1.04	1.11	0.91	1.03	1.04	1.03	1.02
Val	ME799694	1.05	0.88	0.93	1.08	0.93	1.02	1.10	0.94	1.02	1.03	1.02	0.96
HArg	ME799703	0.87	1.16	0.88	1.13	0.88	0.96	0.96	1.35	1.02	1.18	1.02	0.96
Ala	ME799675	0.92	1.06	0.89	0.87	0.89	1.02	1.03	1.21	1.08	0.94	1.08	1.14
Arg	ME799676	0.89	0.95	0.82	0.95	0.82	1.07	1.12	1.12	1.12	0.98	1.12	1.12
Asn	ME799677	0.95	1.06	0.82	1.09	0.82	1.11	1.03	1.24	0.99	1.12	0.99	1.16
Gln	ME799680	0.93	1.02	0.89	1.01	0.89	1.11	1.01	1.15	1.02	1.03	1.02	1.14
Choline	ME799724	1.00	0.99	0.84	1.07	0.84	0.97	1.03	1.09	1.05	1.12	1.05	1.15
Ser	ME799690	0.99	0.97	0.80	1.09	0.80	1.01	1.10	1.15	1.04	1.15	1.04	1.08
GABA	ME799715	0.96	1.05	0.85	1.08	0.85	0.90	1.04	1.15	1.07	1.15	1.07	1.00
Lys	ME799686	0.99	0.97	0.85	1.07	0.85	0.98	1.13	1.13	1.05	1.05	1.05	0.95
ADMA	ME799698	1.00	0.96	0.92	0.99	0.92	0.98	1.04	1.04	1.05	1.01	1.05	1.05
His	ME799683	0.98	0.90	0.91	1.02	0.91	1.00	1.05	1.03	1.06	1.08	1.06	1.04
alpha-AAA	ME799699	0.97	1.05	0.87	1.17	0.87	1.06	1.01	1.06	1.01	1.13	1.01	1.08
Met	ME799687	1.00	1.02	0.92	1.08	0.92	1.05	1.01	1.10	1.00	1.05	1.00	1.02
3-IPA	ME799721	0.80	1.20	0.84	1.16	0.84	1.10	0.83	1.47	0.93	1.41	0.93	1.32
Betaine	ME799700	0.96	1.14	0.97	1.17	0.97	1.40	0.84	1.06	0.88	0.95	0.88	1.28
Pro	ME799689	1.07	1.09	0.76	1.16	0.76	1.19	1.15	1.22	0.88	1.14	0.88	1.19
Thr	ME799691	0.91	1.19	0.79	1.19	0.79	1.15	1.01	1.34	0.94	1.20	0.94	1.16
1-Met-His	ME799695	0.75	0.90	0.93	1.19	0.93	1.24	0.82	0.96	1.10	1.18	1.10	1.25
Cit	ME799701	0.88	1.03	0.85	1.09	0.85	1.34	0.92	1.16	0.97	1.10	0.97	1.40
Gly	ME799682	0.85	1.08	0.85	1.15	0.85	1.15	0.93	1.22	1.02	1.18	1.02	1.18
Creatinine	ME799702	0.84	1.08	0.87	1.21	0.87	1.26	0.89	1.16	0.98	1.17	0.98	1.24
SDMA	ME799710	0.86	1.01	0.86	1.18	0.86	1.21	0.92	1.14	0.99	1.24	0.99	1.26
HipAcid	ME799718	1.22	0.56	0.76	0.93	0.76	1.58	1.28	0.64	0.84	1.07	0.84	1.82
TMAO	ME799674	0.92	0.98	0.70	0.80	0.70	2.01	1.03	1.22	0.83	0.82	0.83	2.14
HCys	ME799704	0.74	1.04	0.64	1.07	0.64	1.46	1.00	1.30	0.97	1.28	0.97	1.92
Orn	ME799707	0.85	0.81	0.67	0.97	0.67	1.18	1.13	1.32	0.99	1.37	0.99	1.75
t4-OH-Pro	ME799711	0.89	1.16	0.62	1.92	0.62	1.37	0.93	1.29	0.72	1.95	0.72	1.29
Glu	ME799681	1.51	2.19	0.66	1.85	0.66	1.03	0.83	0.88	0.69	1.03	0.69	0.96
Putrescine	ME799716	0.95	1.95	0.61	1.57	0.61	0.94	0.82	1.60	0.83	1.46	0.83	1.15

Factors:

F1	Sample material:Plasma \| Treatment:after_Aspirin \| Sex:F
F2	Sample material:Plasma \| Treatment:after_Aspirin \| Sex:M
F3	Sample material:Plasma \| Treatment:before_Aspirin \| Sex:F
F4	Sample material:Plasma \| Treatment:before_Aspirin \| Sex:M
F5	Sample material:Plasma \| Treatment:Plasma \| Sex:F
F6	Sample material:Plasma \| Treatment:Plasma \| Sex:M
F7	Sample material:Serum \| Treatment:after_Aspirin \| Sex:F
F8	Sample material:Serum \| Treatment:after_Aspirin \| Sex:M
F9	Sample material:Serum \| Treatment:before_Aspirin \| Sex:F
F10	Sample material:Serum \| Treatment:before_Aspirin \| Sex:M
F11	Sample material:Serum \| Treatment:Serum \| Sex:F
F12	Sample material:Serum \| Treatment:Serum \| Sex:M

Data matrix